I was aware, in an up close and personal kind of way, that environmental concerns drove the exit of CFC-propelled Albuterol inhalers from the market. I remember my doctor raising the issue with me and discussing training me on a new kind of inhaler. I went home and looked it up and found something like this. I can't say I gave it too much thought. But now that I've read this and have to wonder just what that game was about.
I have to say I love the conclusion: large cost increases in out of pocket spending for commercially insured, relatively small drop in utilization for commercially insured, and insufficient data to track the end result for the uninsured. We can speculate, though.